Provider
Arikayce® (amikacin liposome inhalation) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Documents & Forms Results
Displaying 341 - 350 of 3159 results
Provider
Arikayce® (amikacin liposome inhalation) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
Antifungals - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
Pseudobulbar Affect (PBA) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
Pseudobulbar Affect (PBA) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
Zeposia® (ozanimod) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
Xhance® (fluticasone propionate) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
DPP-4 (dipeptidyl peptidase-4) Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
Coverage Exception - Commercial - NetResults Key Rx & Focus Rx
Coverage Exception
Program effective Date: Apr 01, 2025
Provider
Sodium-glucose Co-transporter (SGLT) Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Program effective Date: Apr 01, 2025